More News

30 Dec 2020 Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804
28 Dec 2020 f5 Therapeutics Announces Seed Investment to Advance Targeted Protein Degrader Platform NExMods™
23 Dec 2020 Agios to Focus on Developing and Commercializing Innovative Treatments for Genetically Defined Diseases and Sell Its Oncology Business to Servier for Up to $2 Billion Plus Royalties
23 Dec 2020 Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines Development for Global Health
23 Dec 2020 ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell Therapy Company
22 Dec 2020 Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer
22 Dec 2020 XPose Therapeutics and Accelero Biostructures announce Joint Research Collaboration for the Discovery and Development of Novel Cancer Therapies
22 Dec 2020 Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer
22 Dec 2020 Sosei Heptares and GSK Enter Global Collaboration and License Agreement Targeting Immune Disorders of the Digestive System
22 Dec 2020 Skyhawk and Vertex Establish a Strategic Collaboration to Discover and Develop Novel Small Molecules that Modulate RNA Splicing for Serious Diseases
22 Dec 2020 Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
22 Dec 2020 Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs
18 Dec 2020 Janux Therapeutics Announces Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology using T Cell Engager (TRACTr) Technology
18 Dec 2020 Histogen Announces Filing an Investigational New Drug Application for HST-003
18 Dec 2020 ONK Therapeutics Announces Three Exclusive Option License Agreements, Which Extend and Strengthen its Dual-Targeted NK Cell Therapy Pipeline
18 Dec 2020 Gyroscope Therapeutics and the University of Pennsylvania Announce Research Agreement to Develop Gene Therapies for Serious Eye Diseases
18 Dec 2020 Leading BioSciences and Seneca Biopharma Announce Merger
16 Dec 2020 Lilly Announces Agreement to Acquire Prevail Therapeutics
14 Dec 2020 Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971
12 Dec 2020 AstraZeneca to acquire Alexion, accelerating the Company's strategic and financial development
10 Dec 2020 Gilead Sciences to Acquire MYR GmbH
10 Dec 2020 Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates
08 Dec 2020 Procyon Technologies LLC and Novo Nordisk A/S to Collaborate on the Development of a Stem-Cell Based Therapy for Type 1 Diabetes
08 Dec 2020 PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
08 Dec 2020 Aligos Enters into an Exclusive License and Research Collaboration Agreement with Merck to Discover and Develop an Oligonucleotide Therapy for NASH

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up